Matthew G Johnson

7PUBLICATIONS
14CO-AUTHORS
Medical virologyInfant and child healthClinical microbiologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 14, 2026
Analysis of Virologic and Clinical Predictors for Hospitalization, Supported by Machine Learning, in a Phase 3 Molnupiravir COVID-19 Treatment Trial.

|Jan 27, 2026
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.

Hyoung Jin Kang, Antonio C Arrieta, Catharina Dhooge

|Mar 03, 2025
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study.

Yoseph Caraco, Matthew G Johnson, Joseph A Chiarappa

|Apr 09, 2024
Molnupiravir: Mechanism of action, clinical, and translational science.

Brian M Maas, Julie Strizki, Randy R Miller

|Feb 01, 2024
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).

Matthew G Johnson, Julie M Strizki, Erin Jensen

|Sep 12, 2023
Subgroup analysis of phase 2 study of ceftolozane/tazobactam in neonates and young infants with pyelonephritis.

Emmanuel Roilides, John S Bradley, Julia Lonchar

Pageof 2

Frequent Collaborators

2 joint publications

Julie Strizki

2 joint publications

Dorothy McCoy

2 joint publications

Brian M Maas

2 joint publications

Carisa De Anda